HIGH MICROSATELLITE INSTABILITY COLORECTAL CARCINOMA

Clinical trials for HIGH MICROSATELLITE INSTABILITY COLORECTAL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new HIGH MICROSATELLITE INSTABILITY COLORECTAL CARCINOMA trials appear

Sign up with your email to follow new studies for HIGH MICROSATELLITE INSTABILITY COLORECTAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

New drug combo enters human testing for Tough-to-Treat cancers

Disease control Ongoing

This is an early-stage study to find a safe dose of a new drug called KFA115, both by itself and combined with an existing immunotherapy (pembrolizumab). It involves about 126 adults with various advanced cancers that have stopped responding to standard treatments. The main goal …

Matched conditions: HIGH MICROSATELLITE INSTABILITY COLORECTAL CARCINOMA

Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated Apr 03, 2026 23:04 UTC

HIGH MICROSATELLITE INSTABILITY COLORECTAL CARCINOMA

Get alerted when new HIGH MICROSATELLITE INSTABILITY COLORECTAL CARCINOMA trials appear

New drug combo enters human testing for Tough-to-Treat cancers